Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lauritano

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 14, 2004
Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptomsA Lupascu, A Armuzzi, B De Pascalis, et al.
European Review for Medical and Pharmacological Sciences|April 16, 2010
The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trialV Ojetti, G Gigante, M Gabrielli, et al.
Digestive Diseases (Basel, Switzerland)|April 24, 2008
Probiotics: which and when?E Scarpellini, A Cazzato, C Lauritano, et al.
Marine Environmental Research|August 18, 2014
Response of the seagrass Posidonia oceanica to different light environments: Insights from a combined molecular and photo-physiological studyE Dattolo, M Ruocco, C Brunet, et al.
The American Journal of Gastroenterology|September 4, 2009
The interaction between small intestinal bacterial overgrowth and warfarin treatmentEmidio Scarpellini, Maurizio Gabrielli, Tommaso Za, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2005
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndromeA Lupascu, M Gabrielli, E C Lauritano, et al.
European Review for Medical and Pharmacological Sciences|February 25, 2021
High levels of mid-regional proadrenomedullin in ARDS COVID-19 patients: the experience of a single, Italian CenterI Benedetti, D Spinelli, T Callegari, et al.
Alimentary Pharmacology & Therapeutics|June 4, 2005
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowthG Nucera, M Gabrielli, A Lupascu, et al.
Alimentary Pharmacology & Therapeutics|June 21, 2005
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowthE C Lauritano, M Gabrielli, A Lupascu, et al.
The American Journal of Gastroenterology|September 20, 2008
Small intestinal bacterial overgrowth recurrence after antibiotic therapyErnesto C Lauritano, Maurizio Gabrielli, Emidio Scarpellini, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 14, 2004
Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptomsA Lupascu, A Armuzzi, B De Pascalis, et al.
European Review for Medical and Pharmacological Sciences|April 16, 2010
The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trialV Ojetti, G Gigante, M Gabrielli, et al.
Digestive Diseases (Basel, Switzerland)|April 24, 2008
Probiotics: which and when?E Scarpellini, A Cazzato, C Lauritano, et al.
Marine Environmental Research|August 18, 2014
Response of the seagrass Posidonia oceanica to different light environments: Insights from a combined molecular and photo-physiological studyE Dattolo, M Ruocco, C Brunet, et al.
The American Journal of Gastroenterology|September 4, 2009
The interaction between small intestinal bacterial overgrowth and warfarin treatmentEmidio Scarpellini, Maurizio Gabrielli, Tommaso Za, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2005
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndromeA Lupascu, M Gabrielli, E C Lauritano, et al.
European Review for Medical and Pharmacological Sciences|February 25, 2021
High levels of mid-regional proadrenomedullin in ARDS COVID-19 patients: the experience of a single, Italian CenterI Benedetti, D Spinelli, T Callegari, et al.
Alimentary Pharmacology & Therapeutics|June 4, 2005
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowthG Nucera, M Gabrielli, A Lupascu, et al.
Alimentary Pharmacology & Therapeutics|June 21, 2005
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowthE C Lauritano, M Gabrielli, A Lupascu, et al.
The American Journal of Gastroenterology|September 20, 2008
Small intestinal bacterial overgrowth recurrence after antibiotic therapyErnesto C Lauritano, Maurizio Gabrielli, Emidio Scarpellini, et al.
Pageof 3